NCT01245764 2018-11-14GARDASILâ„¢ Study in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa (V501-046)Merck Sharp & Dohme LLCPhase 3 Completed250 enrolled 20 charts
NCT00551187 2015-06-08A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED)Merck Sharp & Dohme LLCPhase 2 Completed620 enrolled